Lorlatinib
Lorlatinib market is segmented by region (country), players, by Type and by Application. Players, ... Read More
Global and United States Niraparib Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Niraparib Product Introduction
1.2 Global Niraparib Outlook 2017 VS 2022 VS 2028
1.2.1 Global Niraparib Sales in US$ Million for the Year 2017-2028
1.2.2 Global Niraparib Sales in Volume for the Year 2017-2028
1.3 United States Niraparib Outlook 2017 VS 2022 VS 2028
1.3.1 United States Niraparib Sales in US$ Million for the Year 2017-2028
1.3.2 United States Niraparib Sales in Volume for the Year 2017-2028
1.4 Niraparib Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Niraparib in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Niraparib Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Niraparib Market Dynamics
1.5.1 Niraparib Industry Trends
1.5.2 Niraparib Market Drivers
1.5.3 Niraparib Market Challenges
1.5.4 Niraparib Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Niraparib Market Segment by Type
2.1.1 100mg*30 Capsules
2.1.2 100mg*60 Capsules
2.1.3 100mg*90 Capsules
2.2 Global Niraparib Market Size by Type
2.2.1 Global Niraparib Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Niraparib Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Niraparib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Niraparib Market Size by Type
2.3.1 United States Niraparib Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Niraparib Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Niraparib Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Niraparib Market Segment by Application
3.1.1 Recurrent Epithelial Ovarian Cancer
3.1.2 Fallopian Tube Cancer
3.1.3 Primary Peritoneal Cancer
3.1.4 Other
3.2 Global Niraparib Market Size by Application
3.2.1 Global Niraparib Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Niraparib Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Niraparib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Niraparib Market Size by Application
3.3.1 United States Niraparib Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Niraparib Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Niraparib Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Niraparib Competitor Landscape by Company
4.1 Global Niraparib Market Size by Company
4.1.1 Top Global Niraparib Manufacturers Ranked by Revenue (2021)
4.1.2 Global Niraparib Revenue by Manufacturer (2017-2022)
4.1.3 Global Niraparib Sales by Manufacturer (2017-2022)
4.1.4 Global Niraparib Price by Manufacturer (2017-2022)
4.2 Global Niraparib Concentration Ratio (CR)
4.2.1 Niraparib Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Niraparib in 2021
4.2.3 Global Niraparib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Niraparib Manufacturing Base Distribution, Product Type
4.3.1 Global Niraparib Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Niraparib Product Type
4.3.3 Date of International Manufacturers Enter into Niraparib Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Niraparib Market Size by Company
4.5.1 Top Niraparib Players in United States, Ranked by Revenue (2021)
4.5.2 United States Niraparib Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Niraparib Sales by Players (2020, 2021 & 2022)
5 Global Niraparib Market Size by Region
5.1 Global Niraparib Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Niraparib Market Size in Volume by Region (2017-2028)
5.2.1 Global Niraparib Sales in Volume by Region: 2017-2022
5.2.2 Global Niraparib Sales in Volume Forecast by Region (2023-2028)
5.3 Global Niraparib Market Size in Value by Region (2017-2028)
5.3.1 Global Niraparib Sales in Value by Region: 2017-2022
5.3.2 Global Niraparib Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Niraparib Market Size YoY Growth 2017-2028
6.1.2 North America Niraparib Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Niraparib Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Niraparib Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Niraparib Market Size YoY Growth 2017-2028
6.3.2 Europe Niraparib Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Niraparib Market Size YoY Growth 2017-2028
6.4.2 Latin America Niraparib Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Niraparib Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Niraparib Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 TESARO
7.1.1 TESARO Corporation Information
7.1.2 TESARO Description and Business Overview
7.1.3 TESARO Niraparib Sales, Revenue and Gross Margin (2017-2022)
7.1.4 TESARO Niraparib Products Offered
7.1.5 TESARO Recent Development
7.2 Everest Pharmaceuticals Limited
7.2.1 Everest Pharmaceuticals Limited Corporation Information
7.2.2 Everest Pharmaceuticals Limited Description and Business Overview
7.2.3 Everest Pharmaceuticals Limited Niraparib Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Everest Pharmaceuticals Limited Niraparib Products Offered
7.2.5 Everest Pharmaceuticals Limited Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Niraparib Industry Chain Analysis
8.2 Niraparib Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Niraparib Distributors
8.3 Niraparib Production Mode & Process
8.4 Niraparib Sales and Marketing
8.4.1 Niraparib Sales Channels
8.4.2 Niraparib Distributors
8.5 Niraparib Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Niraparib CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Niraparib Market Trends
Table 3. Niraparib Market Drivers
Table 4. Niraparib Market Challenges
Table 5. Niraparib Market Restraints
Table 6. Global Niraparib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Niraparib Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Niraparib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Niraparib Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Niraparib Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Niraparib Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Niraparib Revenue Share by Manufacturer, 2017-2022
Table 13. Global Niraparib Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Niraparib Sales Share by Manufacturer, 2017-2022
Table 15. Global Niraparib Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Niraparib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Niraparib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Niraparib as of 2021)
Table 18. Top Players of Niraparib in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Niraparib Product Type
Table 20. Date of International Manufacturers Enter into Niraparib Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Niraparib Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Niraparib Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Niraparib Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Niraparib Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Niraparib Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Niraparib Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Niraparib Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Niraparib Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Niraparib Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Niraparib Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Niraparib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Niraparib Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Niraparib Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Niraparib Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Niraparib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Niraparib Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Niraparib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Niraparib Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Niraparib Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Niraparib Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. TESARO Corporation Information
Table 43. TESARO Description and Business Overview
Table 44. TESARO Niraparib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. TESARO Niraparib Product
Table 46. TESARO Recent Development
Table 47. Everest Pharmaceuticals Limited Corporation Information
Table 48. Everest Pharmaceuticals Limited Description and Business Overview
Table 49. Everest Pharmaceuticals Limited Niraparib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Everest Pharmaceuticals Limited Product
Table 51. Everest Pharmaceuticals Limited Recent Development
Table 52. Key Raw Materials Lists
Table 53. Raw Materials Key Suppliers Lists
Table 54. Niraparib Customers List
Table 55. Niraparib Distributors List
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Niraparib Product Picture
Figure 2. Global Niraparib Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Niraparib Market Size 2017-2028 (US$ Million)
Figure 4. Global Niraparib Sales 2017-2028 (K Pcs)
Figure 5. United States Niraparib Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Niraparib Market Size 2017-2028 (US$ Million)
Figure 7. United States Niraparib Sales 2017-2028 (K Pcs)
Figure 8. United States Niraparib Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Niraparib Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Niraparib Report Years Considered
Figure 11. Product Picture of 100mg*30 Capsules
Figure 12. Product Picture of 100mg*60 Capsules
Figure 13. Product Picture of 100mg*90 Capsules
Figure 14. Global Niraparib Market Share by Type in 2022 & 2028
Figure 15. Global Niraparib Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Niraparib Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Niraparib Sales by Type (2017-2028) & (K Pcs)
Figure 18. Global Niraparib Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Niraparib Price by Type (2017-2028) & (USD/Pcs)
Figure 20. United States Niraparib Market Share by Type in 2022 & 2028
Figure 21. United States Niraparib Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Niraparib Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Niraparib Sales by Type (2017-2028) & (K Pcs)
Figure 24. United States Niraparib Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Niraparib Price by Type (2017-2028) & (USD/Pcs)
Figure 26. Product Picture of Recurrent Epithelial Ovarian Cancer
Figure 27. Product Picture of Fallopian Tube Cancer
Figure 28. Product Picture of Primary Peritoneal Cancer
Figure 29. Product Picture of Other
Figure 30. Global Niraparib Market Share by Application in 2022 & 2028
Figure 31. Global Niraparib Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Niraparib Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Niraparib Sales by Application (2017-2028) & (K Pcs)
Figure 34. Global Niraparib Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Niraparib Price by Application (2017-2028) & (USD/Pcs)
Figure 36. United States Niraparib Market Share by Application in 2022 & 2028
Figure 37. United States Niraparib Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Niraparib Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Niraparib Sales by Application (2017-2028) & (K Pcs)
Figure 40. United States Niraparib Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Niraparib Price by Application (2017-2028) & (USD/Pcs)
Figure 42. North America Niraparib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 43. North America Niraparib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Niraparib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 47. Europe Niraparib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Niraparib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 54. Asia-Pacific Niraparib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Niraparib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 66. Latin America Niraparib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Niraparib Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 71. Middle East & Africa Niraparib Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Niraparib Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Niraparib Value Chain
Figure 76. Niraparib Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
TESARO Everest Pharmaceuticals Limited